Ameritas Investment Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.4K Hold
6,547
﹤0.01% 2445
2025
Q4
$31.5K Hold
6,547
﹤0.01% 2404
2025
Q3
$33.1K Hold
6,547
﹤0.01% 2432
2025
Q2
$26.4K Buy
6,547
+2,338
+56% +$7.61K ﹤0.01% 2539
2025
Q1
$11.5K Hold
4,209
﹤0.01% 2779
2024
Q4
$17.9K Hold
4,209
﹤0.01% 2681
2024
Q3
$12.4K Hold
4,209
﹤0.01% 2858
2024
Q2
$14.6K Hold
4,209
﹤0.01% 2756
2024
Q1
$12K Hold
4,209
﹤0.01% 2768
2023
Q4
$14.9K Hold
4,209
﹤0.01% 2715
2023
Q3
$10.9K Hold
4,209
﹤0.01% 2807
2023
Q2
$16.6K Hold
4,209
﹤0.01% 2656
2023
Q1
$14.2K Hold
4,209
﹤0.01% 2587
2022
Q4
$18.5K Hold
4,209
﹤0.01% 2596
2022
Q3
$16K Hold
4,209
﹤0.01% 2617
2022
Q2
$18K Buy
+4,209
New +$30.4K ﹤0.01% 2589

Other funds holding SRTA

Ameritas Investment Partners's SRTA Position: Q1 2026 in Review

Ameritas Investment Partners held its Strata Critical Medical Inc (SRTA) position steady in Q1 2026 at 6,547 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2445.

Ameritas Investment Partners first reported a position in SRTA in Q2 2022 and has held it in 16 quarters since. The position peaked at $33.1K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Ameritas Investment Partners held 6,547 shares of Strata Critical Medical Inc worth $27.4K as of Q1 2026.
  • Ameritas Investment Partners left its Strata Critical Medical Inc share count unchanged in Q1 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2445 holding.
  • Ameritas Investment Partners first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 16 quarters since.
  • Ameritas Investment Partners's Strata Critical Medical Inc position peaked at $33.1K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.